摘要
目的:对不同孕期妊娠大鼠给予黄芩水提液,采用HPLC-MS研究透过胎盘屏障的药物成分。方法:早、中、晚孕期Wistar大鼠灌胃黄芩水提液,连续给药5 d,末次给药后1.5,12 h,取母体血浆(母血)及胚胎组织,检测生物样品中所含药物成分。结果:实验剂量下,各孕期孕鼠血浆中均检测到了7个化合物,明确归属的化合物有黄芩苷、汉黄芩苷、黄芩素、汉黄芩素、千层纸素A。各孕期胚胎组织中,早期检测到7个化合物,包括已归属的5个化合物;中期未检测到待测成分;晚期检测到除黄芩素以外的6个化合物。结论:大鼠妊娠不同时期给药黄芩后,除孕中期外,孕早、晚期胚胎组织中均可检测到黄芩中的药物成分,提示在妊娠期应用黄芩可以造成胎儿的宫内暴露,应对其进一步进行胚胎毒性研究。
Objective： To study ingredients penetrable through placental barrier by administering pregnant rats with Scutellaria Radix extract using HPLC-MS. Method： Rats in early, middle and late pregnancy were intragastrically administered with Scutellaria Radix extract for 5 days. Maternal plasma and embryonic tissues were obtained at 1.5, 12 h after the final administration of Scutellaria Radix extract to determine ingredients of biological specimens. Result： Under the optimum experimental, conditions, seven compounds were detected in all pregnant rat plasma, specifically including baicalin, wogonoside, baicalein, wogonin and oroxylin A. The seven compounds were also discovered in embryonic tissues of rats in early pregnancy, including the five detected compounds. But they were not detected in embryonic tissues of rats in middle pregnancy, and six compounds except baicalein were detected embryonic tissues of rats in late pregnancy. Conclusion： Ingredients contained in Scutellaria Radix are detected in pregnant rats at different stages, except those in middle pregnancy, indicating a potential in utero exposure in case of oral administration of Scutellaria Radix pregnancy. Therefore, a study of embryotoxicity shall be continued to evaluate the safety of Scntellaria Radix extract.
出处
《中国中药杂志》
CAS
CSCD
北大核心
2012年第3期327-330,共4页
China Journal of Chinese Materia Medica
基金
国家科技部中医药行业专项(200707011)
